NKE enters the week with its sharpest single analyst blow in months — a JPMorgan downgrade landing on a stock already down more than a third year-to-date and trading at levels last seen in the mid-$40s in 2017.
The most telling signal this week is in options, where defensive positioning has jumped to its most elevated reading in at least a year. The put/call ratio hit 0.84 on Tuesday, more than two standard deviations above its 20-day average of 0.77 — a z-score of 2.27 that places current hedging demand close to the 52-week high of 0.95. That is a meaningful shift from the 0.72-0.73 readings that prevailed through most of July, suggesting the JPMorgan move catalysed a fresh wave of downside protection buying. The stock itself has fallen 3.5% on the week and 5.8% over the past month, closing at $41.53 on Tuesday.
Short interest paints a more nuanced picture. At 5.1% of the free float — roughly 60.9 million shares — bears are present but not crowding in. Short interest has actually eased about 3% week-on-week, pulling back from a mid-July peak near 70.7 million shares. The borrow market remains wide open: availability is running at over 2,000% of current short interest, meaning shares are plentiful for anyone wanting to initiate a new position. Cost to borrow, while up 33% on the week to 0.52%, is still trivially low in absolute terms. Positioning looks cautious rather than structurally pressured — options traders are hedging, but short sellers are not piling on.
The Street's mood shifted visibly this week. JPMorgan's Matthew Boss downgraded NKE to Underweight and cut his target to $40 — now fractionally below the current price — citing persistent macro headwinds and limited near-term catalysts. That is a meaningful move from a bellwether firm. The broader analyst picture is similarly subdued: a wave of cuts followed the most recent earnings on July 1, with UBS, Citigroup, Stifel, Telsey, and Guggenheim all lowering targets while holding neutral or mixed ratings. Jefferies and Bernstein remain buyers but trimmed targets sharply, to $75 and $72 respectively, well above where the stock is trading. The consensus mean target sits near $50.70, implying roughly 22% upside from current levels — but with the stock below several targets set post-earnings, the Street is working through a credibility gap. Bulls point to turnaround progress in performance categories, improving Chinese sell-through, and a September investor day as potential re-rating triggers. Bears flag flat revenue, tariff exposure, and a brand that has ceded ground to faster-growing competitors.
Insider activity earlier in the year adds a layer of context worth noting. In April, CEO Elliott Hill bought nearly $1 million of stock at $42.27, and Apple's Tim Cook — serving as lead independent director — added $1.06 million at $42.43. Both purchases occurred within cents of where NKE trades today. Those cluster buys carried a trade significance score of 3, modest by absolute standards, but the CEO buying near current levels is not a detail to dismiss entirely. More recent insider activity, from June, was comprised of smaller EVP sales — routine in character.
Among peers, the week has been broadly weak for footwear and apparel. COLM fell 10.7% and WWW dropped 7.3%, while ONON held relatively firm at down 0.7% and AS was essentially flat. NKE's 3.5% weekly decline sits in the middle of that range, suggesting the sector backdrop is also deteriorating rather than NKE moving in isolation. With the next earnings event scheduled for September 8, the focus over the coming weeks will be whether the company's management can shift the narrative ahead of what could be a pivotal investor day — and whether the JPMorgan downgrade prompts further target cuts from the several analysts still holding targets well north of $50.
See the live data behind this article on ORTEX.
Open NKE on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
